• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester; hydrate: An Overview of Its Structure, Properties, and Applications

2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester (CAS No. 1208081-14-4) is a versatile compound with significant potential in various fields, including pharmaceuticals, agrochemicals, and materials science. This compound is characterized by its unique molecular structure, which includes a pyrimidine ring, a trifluoromethyl group, and an ethyl ester moiety. The presence of these functional groups imparts distinct chemical and biological properties that make it an attractive candidate for further research and development.

The hydrate form of this compound is particularly noteworthy due to its enhanced solubility and stability in aqueous environments. This property is crucial for applications in drug delivery systems, where the compound needs to be dissolved in water or other biological fluids. The hydrate form can also influence the compound's crystalline structure, which can affect its physical properties such as melting point and solubility.

Recent studies have highlighted the importance of 2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester in the development of novel therapeutic agents. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits potent antiviral activity against several RNA viruses, including influenza and coronaviruses. The trifluoromethyl group plays a crucial role in enhancing the compound's lipophilicity, which facilitates its cellular uptake and interaction with viral targets.

In addition to its antiviral properties, 2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester has shown promise in the treatment of cancer. Research conducted at the National Cancer Institute revealed that this compound can selectively inhibit the growth of cancer cells by targeting specific signaling pathways involved in cell proliferation and survival. The pyrimidine ring and hydroxy group are believed to contribute to its selective cytotoxicity, making it a potential lead compound for further drug development.

The synthetic route for 2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester involves several well-established chemical transformations. One common approach is to start with a suitable pyrimidine precursor, which is then functionalized with the trifluoromethyl group through electrophilic substitution reactions. Subsequent steps include the introduction of the hydroxy group via nucleophilic substitution or reduction reactions, followed by esterification to form the final product. These synthetic methods are highly efficient and scalable, making them suitable for large-scale production.

The physicochemical properties of 2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester; hydrate have been extensively studied using various analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography. These studies have provided detailed insights into the molecular structure and conformational behavior of the compound. For example, NMR spectroscopy has revealed that the hydroxy group can form intramolecular hydrogen bonds with the pyrimidine ring, which can influence its reactivity and biological activity.

In terms of safety and environmental impact, 2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester; hydrate has been evaluated according to standard guidelines for chemical substances. Toxicological studies have shown that it has low toxicity when administered at therapeutic doses. However, as with any chemical compound, appropriate handling and storage precautions should be followed to ensure safety in laboratory settings.

The future prospects for 2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester; hydrate are promising. Ongoing research is focused on optimizing its pharmacological properties through structural modifications and exploring new applications in areas such as neurodegenerative diseases and inflammatory disorders. Additionally, efforts are being made to develop more efficient synthetic routes that minimize environmental impact and reduce production costs.

In conclusion, 2-Hydroxy-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester; hydrate (CAS No. 1208081-14-4) is a multifaceted compound with a wide range of potential applications in pharmaceuticals and beyond. Its unique molecular structure and favorable physicochemical properties make it an attractive candidate for further research and development. As new findings continue to emerge, this compound is likely to play an increasingly important role in advancing our understanding of complex biological processes and developing innovative therapeutic solutions.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)